Michael A.S. Jewett

25.9k total citations · 1 hit paper
418 papers, 15.7k citations indexed

About

Michael A.S. Jewett is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Michael A.S. Jewett has authored 418 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 234 papers in Pulmonary and Respiratory Medicine, 185 papers in Surgery and 154 papers in Molecular Biology. Recurrent topics in Michael A.S. Jewett's work include Renal cell carcinoma treatment (134 papers), Renal and related cancers (105 papers) and Bladder and Urothelial Cancer Treatments (87 papers). Michael A.S. Jewett is often cited by papers focused on Renal cell carcinoma treatment (134 papers), Renal and related cancers (105 papers) and Bladder and Urothelial Cancer Treatments (87 papers). Michael A.S. Jewett collaborates with scholars based in Canada, United States and United Kingdom. Michael A.S. Jewett's co-authors include Antonio Finelli, Andrew Evans, Neil Fleshner, Alessandro Volpe, Padraig Warde, Mary Gospodarowicz, Ricardo Rendon, Alexandre R. Zlotta, John Trachtenberg and John R. Kachura and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Michael A.S. Jewett

408 papers receiving 15.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

2018 306 citations Axel Bex, Michael A.S. Jewett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A.S. Jewett Canada	69	8.9k	6.5k	6.1k	2.5k	2.0k	418	15.7k
Markus A. Kuczyk Germany	47	7.1k 0.8×	5.3k 0.8×	3.3k 0.5×	1.8k 0.7×	1.8k 0.9×	281	11.3k
Stephen A. Boorjian United States	72	12.2k 1.4×	6.4k 1.0×	9.3k 1.5×	2.2k 0.9×	3.9k 2.0×	569	20.8k
Ganesh V. Raj United States	53	5.8k 0.6×	4.0k 0.6×	3.2k 0.5×	1.8k 0.7×	2.2k 1.1×	195	11.5k
Jerome P. Richie United States	54	6.4k 0.7×	4.3k 0.7×	3.4k 0.6×	1.2k 0.5×	1.5k 0.8×	273	13.3k
Harm van Tinteren Netherlands	69	5.7k 0.6×	3.0k 0.5×	6.1k 1.0×	1.8k 0.7×	5.2k 2.6×	340	17.1k
Adam S. Kibel United States	60	8.7k 1.0×	3.3k 0.5×	4.6k 0.8×	2.6k 1.1×	3.4k 1.7×	605	15.9k
Paul H. Lange United States	60	7.4k 0.8×	2.9k 0.4×	3.5k 0.6×	1.3k 0.5×	2.1k 1.1×	265	12.6k
Robert Huddart United Kingdom	62	5.6k 0.6×	2.7k 0.4×	7.8k 1.3×	910 0.4×	3.2k 1.6×	388	14.9k
Kurt Miller Germany	59	9.1k 1.0×	4.6k 0.7×	2.1k 0.4×	3.5k 1.4×	2.9k 1.5×	358	14.7k
Bradley C. Leibovich United States	81	17.9k 2.0×	11.1k 1.7×	7.1k 1.2×	3.9k 1.6×	6.0k 3.0×	456	24.4k

Countries citing papers authored by Michael A.S. Jewett

Since Specialization

Citations

This map shows the geographic impact of Michael A.S. Jewett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A.S. Jewett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A.S. Jewett more than expected).

Fields of papers citing papers by Michael A.S. Jewett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A.S. Jewett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A.S. Jewett. The network helps show where Michael A.S. Jewett may publish in the future.

Co-authorship network of co-authors of Michael A.S. Jewett

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A.S. Jewett. A scholar is included among the top collaborators of Michael A.S. Jewett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A.S. Jewett. Michael A.S. Jewett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kanabur, Pratik, Riccardo Campi, Maxine Tran, et al.. (2025). ‘ BJUI Clinical Dilemma’: the incidental small renal mass in a solitary kidney. British Journal of Urology. 135(3). 371–379.

Marandino, Laura, Maarten Albersen, Umberto Capitanio, et al.. (2025). Quality Indicators for Renal Cancer Care: A Systematic Review. European Urology Oncology. 8(5). 1416–1427.

Atenafu, Eshetu G., et al.. (2024). Lymph node density as a prognostic marker of relapse in patients who underwent primary retroperitoneal lymph node dissection. Urologic Oncology Seminars and Original Investigations. 42(12). 455.e1–455.e8.

Kulkarni, Girish S., Kyle A. Richards, Peter C. Black, et al.. (2023). MP63-01 AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS). The Journal of Urology. 209(Supplement 4). 3 indexed citations

Nason, Gregory J., Joan Sweet, Ricardo Leão, et al.. (2020). Discrepancy in pathology reports upon second review of radical orchiectomy specimens for testicular germ cell tumors. Canadian Urological Association Journal. 14(12). 411–415. 4 indexed citations

Goldberg, Hanan, Jaime O. Herrera‐Cáceres, Alejandro Berlín, et al.. (2020). Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass. Urologic Oncology Seminars and Original Investigations. 38(6). 603.e17–603.e25. 21 indexed citations

Meo, Ashley Di, Marshall Brown, Antonio Finelli, et al.. (2019). Prognostic urinary miRNAs for the assessment of small renal masses. Clinical Biochemistry. 75. 15–22. 23 indexed citations

Meo, Ashley Di, Ihor Batruch, Marshall Brown, et al.. (2019). Searching for prognostic biomarkers for small renal masses in the urinary proteome. International Journal of Cancer. 146(8). 2315–2325. 29 indexed citations

Lewin, Jeremy, Laleh Soltan Ghoraie, Philippe L. Bédard, et al.. (2018). Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours. British Journal of Urology. 122(5). 814–822. 8 indexed citations

10.

Putte, Elisabeth E. Fransen van de, Judith Bosschieter, Theodorus van der Kwast, et al.. (2018). The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer. British Journal of Urology. 122(6). 978–985. 23 indexed citations

11.

Hosni, Ali, Padraig Warde, Michael A.S. Jewett, et al.. (2016). Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma. Clinical Oncology. 28(10). 648–654. 12 indexed citations

12.

Boström, Peter J., Tuomas Mirtti, Bas van Rhijn, et al.. (2016). Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy. Bladder Cancer. 2(2). 263–272. 6 indexed citations

13.

Haas, Naomi B., Judith Manola, Bonnie Ky, et al.. (2015). Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805. Clinical Cancer Research. 21(18). 4048–4054. 46 indexed citations

14.

Khella, Heba, Andreas Scorilas, Evi Lianidou, et al.. (2015). Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma. American Journal Of Pathology. 185(3). 693–703. 56 indexed citations

15.

Khella, Heba, Andrew H. Girgis, Andreas Scorilas, et al.. (2014). miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma. Journal of Molecular Diagnostics. 17(2). 136–144. 53 indexed citations

16.

Jewett, Michael A.S., et al.. (2013). Canadian Kidney Cancer Forum 2008. Canadian Urological Association Journal. 2(3). 183–183. 4 indexed citations

17.

Kurban, Ghada, Brenda L. Gallie, Michael Leveridge, et al.. (2011). Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: Observations on DNA, RNA, protein extractions and VHL mutation detection. Pathology - Research and Practice. 208(1). 22–31. 11 indexed citations

18.

Maynard, Mindy A., et al.. (2005). Human HIF‐3α4 is a dominant‐negative regulator of HIF‐1 and is down‐regulated in renal cell carcinoma. The FASEB Journal. 19(11). 1396–1406. 161 indexed citations

19.

Evans, Andrew, Brenda L. Gallie, Michael A.S. Jewett, et al.. (2004). Defining a 0.5-Mb Region of Genomic Gain on Chromosome 6p22 in Bladder Cancer by Quantitative-Multiplex Polymerase Chain Reaction. American Journal Of Pathology. 164(1). 285–293. 45 indexed citations

20.

Al‐Maghrabi, Jaudah, et al.. (2001). p53 Alteration and Chromosomal Instability in Prostatic High-Grade Intraepithelial Neoplasia and Concurrent Carcinoma: Analysis by Immunohistochemistry, Interphase In Situ Hybridization, and Sequencing of Laser-Captured Microdissected Specimens. Modern Pathology. 14(12). 1252–1262. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact